Pub. Date : 2009 Oct 15
PMID : 19783684
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha). | 3,3',4,5'-tetrahydroxystilbene | spleen associated tyrosine kinase | Homo sapiens |
2 | Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha). | 3,3',4,5'-tetrahydroxystilbene | spleen associated tyrosine kinase | Homo sapiens |
3 | Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha). | 3,3',4,5'-tetrahydroxystilbene | spleen associated tyrosine kinase | Homo sapiens |
4 | Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha). | 3,3',4,5'-tetrahydroxystilbene | spleen associated tyrosine kinase | Homo sapiens |